Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Rocket Pharmaceuticals (RCKT) Return on Capital Employed (2017 - 2025)

Historic Return on Capital Employed for Rocket Pharmaceuticals (RCKT) over the last 9 years, with Q3 2025 value amounting to 0.69%.

  • Rocket Pharmaceuticals' Return on Capital Employed rose 300.0% to 0.69% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.69%, marking a year-over-year increase of 300.0%. This contributed to the annual value of 0.54% for FY2024, which is 300.0% down from last year.
  • Rocket Pharmaceuticals' Return on Capital Employed amounted to 0.69% in Q3 2025, which was up 300.0% from 0.66% recorded in Q2 2025.
  • Over the past 5 years, Rocket Pharmaceuticals' Return on Capital Employed peaked at 0.28% during Q1 2021, and registered a low of 0.72% during Q3 2024.
  • For the 5-year period, Rocket Pharmaceuticals' Return on Capital Employed averaged around 0.51%, with its median value being 0.51% (2022).
  • As far as peak fluctuations go, Rocket Pharmaceuticals' Return on Capital Employed plummeted by -1900bps in 2024, and later soared by 300bps in 2025.
  • Rocket Pharmaceuticals' Return on Capital Employed (Quarter) stood at 0.34% in 2021, then tumbled by -48bps to 0.5% in 2022, then grew by 3bps to 0.49% in 2023, then plummeted by -34bps to 0.65% in 2024, then dropped by -6bps to 0.69% in 2025.
  • Its Return on Capital Employed was 0.69% in Q3 2025, compared to 0.66% in Q2 2025 and 0.58% in Q1 2025.